LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 8 of total 8

Search options

  1. Article: ADAM17-Mediated Shedding of Inflammatory Cytokines in Hypertension.

    de Queiroz, Thyago M / Lakkappa, Navya / Lazartigues, Eric

    Frontiers in pharmacology

    2020  Volume 11, Page(s) 1154

    Abstract: The increase of Angiontesin-II (Ang-II), one of the key peptides of the renin-angiotensin system (RAS), and its binding to the Ang-II type 1 receptor ( ... ...

    Abstract The increase of Angiontesin-II (Ang-II), one of the key peptides of the renin-angiotensin system (RAS), and its binding to the Ang-II type 1 receptor (AT
    Keywords covid19
    Language English
    Publishing date 2020-07-29
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2587355-6
    ISSN 1663-9812
    ISSN 1663-9812
    DOI 10.3389/fphar.2020.01154
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Involvement of shedding induced by ADAM17 on the nitric oxide pathway in hypertension.

    da Silva, Mirelly Cunha / Dos Santos, Vanessa Maria / da Silva, Matheus Vinícius B / Prazeres, Tereza Cristina M M / Cartágenes, Maria do Socorro S / Calzerra, Natália Tabosa M / de Queiroz, Thyago Moreira

    Frontiers in molecular biosciences

    2022  Volume 9, Page(s) 1032177

    Abstract: A Disintegrin and Metalloprotease 17 (ADAM17), also called tumor necrosis factor-ɑ (TNF-ɑ) convertase (TACE), is a well-known protease involved in the sheddase of growth factors, chemokines and cytokines. ADAM17 is also enrolled in hypertension, ... ...

    Abstract A Disintegrin and Metalloprotease 17 (ADAM17), also called tumor necrosis factor-ɑ (TNF-ɑ) convertase (TACE), is a well-known protease involved in the sheddase of growth factors, chemokines and cytokines. ADAM17 is also enrolled in hypertension, especially by shedding of angiotensin converting enzyme type 2 (ACE2) leading to impairment of angiotensin 1-7 [Ang-(1-7)] production and injury in vasodilation, induction of renal damage and cardiac hypertrophy. Activation of Mas receptor (MasR) by binding of Ang-(1-7) induces an increase in the nitric oxide (NO) gaseous molecule, which is an essential factor of vascular homeostasis and blood pressure control. On the other hand, TNF-ɑ has demonstrated to stimulate a decrease in nitric oxide bioavailability, triggering a disrupt in endothelium-dependent vasorelaxation. In spite of the previous studies, little knowledge is available about the involvement of the metalloprotease 17 and the NO pathways. Here we will provide an overview of the role of ADAM17 and Its mechanisms implicated with the NO formation.
    Language English
    Publishing date 2022-10-14
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2814330-9
    ISSN 2296-889X
    ISSN 2296-889X
    DOI 10.3389/fmolb.2022.1032177
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Angiotensin-II-derived reactive oxygen species on baroreflex sensitivity during hypertension: new perspectives.

    de Queiroz, Thyago M / Monteiro, Matheus M O / Braga, Valdir A

    Frontiers in physiology

    2013  Volume 4, Page(s) 105

    Abstract: Hypertension is a multifactorial disorder, which has been associated with the reduction in baroreflex sensitivity (BRS) and autonomic dysfunction. Several studies have revealed that increased reactive oxygen species (ROS) generated by nicotinamide ... ...

    Abstract Hypertension is a multifactorial disorder, which has been associated with the reduction in baroreflex sensitivity (BRS) and autonomic dysfunction. Several studies have revealed that increased reactive oxygen species (ROS) generated by nicotinamide adenine dinucleotide phosphate [NAD(P)H] oxidase, following activation of type 1 receptor (AT1R) by Angiotensin-(Ang) II, the main peptide of the Renin-Angiotensin-Aldosterone System (RAAS), is the central mechanism involved in Ang-II-derived hypertension. In the present review, we will discuss the role of Ang II and oxidative stress in hypertension, the relationship between the BRS and the genesis of hypertension and how the oxidative stress triggers baroreflex dysfunction in several models of hypertension. Finally, we will describe some novel therapeutic drugs for improving the BRS during hypertension.
    Language English
    Publishing date 2013-05-13
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2564217-0
    ISSN 1664-042X
    ISSN 1664-042X
    DOI 10.3389/fphys.2013.00105
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: α-Lipoic acid reduces neurogenic hypertension by blunting oxidative stress-mediated increase in ADAM17.

    de Queiroz, Thyago M / Xia, Huijing / Filipeanu, Catalin M / Braga, Valdir A / Lazartigues, Eric

    American journal of physiology. Heart and circulatory physiology

    2015  Volume 309, Issue 5, Page(s) H926–34

    Abstract: We previously reported that type 2 angiotensin-converting enzyme (ACE2) compensatory activity is impaired by the disintegrin and metalloprotease 17 (ADAM17), and lack of ACE2 is associated with oxidative stress in neurogenic hypertension. To investigate ... ...

    Abstract We previously reported that type 2 angiotensin-converting enzyme (ACE2) compensatory activity is impaired by the disintegrin and metalloprotease 17 (ADAM17), and lack of ACE2 is associated with oxidative stress in neurogenic hypertension. To investigate the relationship between ADAM17 and oxidative stress, Neuro2A cells were treated with ANG II (100 nM) 24 h after vehicle or α-lipoic acid (LA, 500 μM). ADAM17 expression was increased by ANG II (120.5 ± 9.1 vs. 100.2 ± 0.8%, P < 0.05) and decreased after LA (69.0 ± 0.3 vs. 120.5 ± 9.1%, P < 0.05). In another set of experiments, LA reduced ADAM17 (92.9 ± 5.3 vs. 100.0 ± 11.2%, P < 0.05) following its overexpression. Moreover, ADAM17 activity was reduced by LA in ADAM17-overexpressing cells [109.5 ± 19.8 vs. 158.0 ± 20.0 fluorescence units (FU)·min(-1)·μg protein(-1), P < 0.05], in which ADAM17 overexpression increased oxidative stress (114.1 ± 2.5 vs. 101.0 ± 1.0%, P < 0.05). Conversely, LA-treated cells attenuated ADAM17 overexpression-induced oxidative stress (76.0 ± 9.1 vs. 114.1 ± 2.5%, P < 0.05). In deoxycorticosterone acetate (DOCA)-salt hypertensive mice, a model in which ADAM17 expression and activity are increased, hypertension was blunted by pretreatment with LA (119.0 ± 2.4 vs. 131.4 ± 2.2 mmHg, P < 0.05). In addition, LA improved dysautonomia and baroreflex sensitivity. Furthermore, LA blunted the increase in NADPH oxidase subunit expression, as well as the increase in ADAM17 and decrease in ACE2 activity in the hypothalamus of DOCA-salt hypertensive mice. Taken together, these data suggest that LA might preserve ACE2 compensatory activity by breaking the feedforward cycle between ADAM17 and oxidative stress, resulting in a reduction of neurogenic hypertension.
    MeSH term(s) ADAM Proteins/genetics ; ADAM Proteins/metabolism ; ADAM17 Protein ; Angiotensin II/pharmacology ; Animals ; Antioxidants/pharmacology ; Antioxidants/therapeutic use ; Baroreflex ; Cell Line, Tumor ; Hypertension/drug therapy ; Hypertension/metabolism ; Hypothalamus/cytology ; Hypothalamus/drug effects ; Hypothalamus/metabolism ; Male ; Mice ; Mice, Inbred C57BL ; NADPH Oxidases/metabolism ; Neurons/drug effects ; Neurons/metabolism ; Oxidative Stress ; Peptidyl-Dipeptidase A/metabolism ; Thioctic Acid/pharmacology ; Thioctic Acid/therapeutic use
    Chemical Substances Antioxidants ; Angiotensin II (11128-99-7) ; Thioctic Acid (73Y7P0K73Y) ; NADPH Oxidases (EC 1.6.3.-) ; Peptidyl-Dipeptidase A (EC 3.4.15.1) ; angiotensin converting enzyme 2 (EC 3.4.17.-) ; ADAM Proteins (EC 3.4.24.-) ; ADAM17 Protein (EC 3.4.24.86) ; Adam17 protein, mouse (EC 3.4.24.86)
    Language English
    Publishing date 2015-08-07
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 603838-4
    ISSN 1522-1539 ; 0363-6135
    ISSN (online) 1522-1539
    ISSN 0363-6135
    DOI 10.1152/ajpheart.00259.2015
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Central administration of TRV027 improves baroreflex sensitivity and vascular reactivity in spontaneously hypertensive rats.

    Carvalho-Galvão, Alynne / Ogunlade, Blessing / Xu, Jiaxi / Silva-Alves, Cristiane R A / Mendes-Júnior, Leônidas G / Guimarães, Drielle D / Cruz, Josiane C / Queiroz, Thyago M / Balarini, Camille M / Braga, Valdir A / Filipeanu, Catalin M / Lazartigues, Eric / de França-Silva, Maria do Socorro

    Clinical science (London, England : 1979)

    2018  Volume 132, Issue 14, Page(s) 1513–1527

    Abstract: TRV027 is a biased agonist for the Angiotensin (Ang)-II type 1 receptor ( ... ...

    Abstract TRV027 is a biased agonist for the Angiotensin (Ang)-II type 1 receptor (AT
    MeSH term(s) Angiotensin II/pharmacology ; Angiotensin-Converting Enzyme 2 ; Animals ; Baroreflex/drug effects ; Baroreflex/physiology ; Blood Pressure/drug effects ; Blood Pressure/physiology ; HEK293 Cells ; Humans ; Hypertension/physiopathology ; Mesenteric Arteries/drug effects ; Mesenteric Arteries/metabolism ; Mesenteric Arteries/physiology ; Oligopeptides/pharmacology ; Peptidyl-Dipeptidase A/metabolism ; Protein Binding/drug effects ; Rats, Inbred SHR ; Rats, Inbred WKY ; Receptor, Angiotensin, Type 1/metabolism ; Vasoconstrictor Agents/pharmacology
    Chemical Substances Oligopeptides ; Receptor, Angiotensin, Type 1 ; Vasoconstrictor Agents ; Angiotensin II (11128-99-7) ; Peptidyl-Dipeptidase A (EC 3.4.15.1) ; ACE2 protein, human (EC 3.4.17.23) ; Ace2 protein, rat (EC 3.4.17.23) ; Angiotensin-Converting Enzyme 2 (EC 3.4.17.23) ; Sar-Arg-Val-Tyr-Ile-His-Pro-Ala-OH (J1J4P3PQZD)
    Language English
    Publishing date 2018-07-23
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 206835-7
    ISSN 1470-8736 ; 0301-0538 ; 0009-0360 ; 0143-5221
    ISSN (online) 1470-8736
    ISSN 0301-0538 ; 0009-0360 ; 0143-5221
    DOI 10.1042/CS20180222
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Reprogramming of Small Noncoding RNA Populations in Peripheral Blood Reveals Host Biomarkers for Latent and Active Mycobacterium tuberculosis Infection.

    de Araujo, Leonardo Silva / Ribeiro-Alves, Marcelo / Leal-Calvo, Thyago / Leung, Janaína / Durán, Verónica / Samir, Mohamed / Talbot, Steven / Tallam, Aravind / Mello, Fernanda Carvalho de Queiroz / Geffers, Robert / Saad, Maria Helena Féres / Pessler, Frank

    mBio

    2019  

    Abstract: ... radiographs. SNORD104 expression decreased during M. tuberculosis infection of primary human peripheral blood ... burden and there remains a great need for better diagnostic biomarkers to detect latent and active M ...

    Abstract In tuberculosis (TB), as in other infectious diseases, studies of small noncoding RNAs (sncRNA) in peripheral blood have focused on microRNAs (miRNAs) but have neglected the other major sncRNA classes in spite of their potential functions in host gene regulation. Using RNA sequencing of whole blood, we have therefore determined expression of miRNA, PIWI-interacting RNA (piRNA), small nucleolar RNA (snoRNA), and small nuclear RNA (snRNA) in patients with TB (n = 8), latent TB infection (LTBI; n = 21), and treated LTBI (LTBItt; n = 6) and in uninfected exposed controls (ExC; n = 14). As expected, sncRNA reprogramming was greater in TB than in LTBI, with the greatest changes seen in miRNA populations. However, substantial dynamics were also evident in piRNA and snoRNA populations. One miRNA and 2 piRNAs were identified as moderately accurate (area under the curve [AUC] = 0.70 to 0.74) biomarkers for LTBI, as were 1 miRNA, 1 piRNA, and 2 snoRNAs (AUC = 0.79 to 0.91) for accomplished LTBI treatment. Logistic regression identified the combination of 4 sncRNA (let-7a-5p, miR-589-5p, miR-196b-5p, and SNORD104) as a highly sensitive (100%) classifier to discriminate TB from all non-TB groups. Notably, it reclassified 8 presumed LTBI cases as TB cases, 5 of which turned out to have features of Mycobacterium tuberculosis infection on chest radiographs. SNORD104 expression decreased during M. tuberculosis infection of primary human peripheral blood mononuclear cells (PBMC) and M2-like (P = 0.03) but not M1-like (P = 0.31) macrophages, suggesting that its downregulation in peripheral blood in TB is biologically relevant. Taken together, the results demonstrate that snoRNA and piRNA should be considered in addition to miRNA as biomarkers and pathogenesis factors in the various stages of TB.IMPORTANCE Tuberculosis is the infectious disease with the worldwide largest disease burden and there remains a great need for better diagnostic biomarkers to detect latent and active M. tuberculosis infection. RNA molecules hold great promise in this regard, as their levels of expression may differ considerably between infected and uninfected subjects. We have measured expression changes in the four major classes of small noncoding RNAs in blood samples from patients with different stages of TB infection. We found that, in addition to miRNAs (which are known to be highly regulated in blood cells from TB patients), expression of piRNA and snoRNA is greatly altered in both latent and active TB, yielding promising biomarkers. Even though the functions of many sncRNA other than miRNA are still poorly understood, our results strongly suggest that at least piRNA and snoRNA populations may represent hitherto underappreciated players in the different stages of TB infection.
    Keywords RNA ; biomarkers ; biosignature ; incipient tuberculosis ; miRNA ; piRNA ; snRNA ; sncRNA ; snoRNA ; subclinical tuberculosis ; transcriptome ; tuberculosis
    Subject code 610
    Publishing date 2019-12-03
    Publisher America Society of Microbiology (ASM)
    Publishing country de
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Acute Treatment with Lauric Acid Reduces Blood Pressure and Oxidative Stress in Spontaneously Hypertensive Rats.

    Alves, Naiane Ferraz Bandeira / de Queiroz, Thyago Moreira / de Almeida Travassos, Rafael / Magnani, Marciane / de Andrade Braga, Valdir

    Basic & clinical pharmacology & toxicology

    2017  Volume 120, Issue 4, Page(s) 348–353

    Abstract: The effects of acute administration of lauric acid (LA), the most abundant medium-chain fatty acid of coconut oil, on blood pressure, heart rate and oxidative stress were investigated in spontaneously hypertensive rats (SHR). Intravenous doses of LA ... ...

    Abstract The effects of acute administration of lauric acid (LA), the most abundant medium-chain fatty acid of coconut oil, on blood pressure, heart rate and oxidative stress were investigated in spontaneously hypertensive rats (SHR). Intravenous doses of LA reduced blood pressure in a dose-dependent fashion (1, 3, 4, 8 and 10 mg/kg) in both SHR and Wistar Kyoto rats. LA (10
    MeSH term(s) Animals ; Antioxidants/administration & dosage ; Antioxidants/therapeutic use ; Blood Pressure/drug effects ; Dose-Response Relationship, Drug ; Endothelium, Vascular/drug effects ; Endothelium, Vascular/metabolism ; Heart Rate/drug effects ; Hypertension/drug therapy ; Hypertension/metabolism ; In Vitro Techniques ; Injections, Intravenous ; Lauric Acids/administration & dosage ; Lauric Acids/therapeutic use ; Mesenteric Artery, Superior/drug effects ; Oxidative Stress/drug effects ; Rats, Inbred SHR ; Rats, Inbred WKY ; Superoxides/metabolism ; Vasoconstrictor Agents/pharmacology ; Vasodilation/drug effects
    Chemical Substances Antioxidants ; Lauric Acids ; Vasoconstrictor Agents ; Superoxides (11062-77-4) ; lauric acid (1160N9NU9U)
    Language English
    Publishing date 2017-04
    Publishing country England
    Document type Journal Article
    ZDB-ID 2134679-3
    ISSN 1742-7843 ; 1742-7835
    ISSN (online) 1742-7843
    ISSN 1742-7835
    DOI 10.1111/bcpt.12700
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Reprogramming of Small Noncoding RNA Populations in Peripheral Blood Reveals Host Biomarkers for Latent and Active Mycobacterium tuberculosis Infection.

    de Araujo, Leonardo Silva / Ribeiro-Alves, Marcelo / Leal-Calvo, Thyago / Leung, Janaína / Durán, Verónica / Samir, Mohamed / Talbot, Steven / Tallam, Aravind / Mello, Fernanda Carvalho de Queiroz / Geffers, Robert / Saad, Maria Helena Féres / Pessler, Frank

    mBio

    2019  Volume 10, Issue 6

    Abstract: In tuberculosis (TB), as in other infectious diseases, studies of small noncoding RNAs (sncRNA) in peripheral blood have focused on microRNAs (miRNAs) but have neglected the other major sncRNA classes in spite of their potential functions in host gene ... ...

    Abstract In tuberculosis (TB), as in other infectious diseases, studies of small noncoding RNAs (sncRNA) in peripheral blood have focused on microRNAs (miRNAs) but have neglected the other major sncRNA classes in spite of their potential functions in host gene regulation. Using RNA sequencing of whole blood, we have therefore determined expression of miRNA, PIWI-interacting RNA (piRNA), small nucleolar RNA (snoRNA), and small nuclear RNA (snRNA) in patients with TB (
    MeSH term(s) Adult ; Biomarkers/metabolism ; Female ; Gene Expression Profiling/methods ; Humans ; Latent Tuberculosis/genetics ; Leukocytes, Mononuclear/metabolism ; Macrophages/metabolism ; Male ; MicroRNAs/genetics ; Middle Aged ; Mycobacterium tuberculosis/pathogenicity ; RNA, Small Untranslated/genetics ; Tuberculosis/genetics
    Chemical Substances Biomarkers ; MicroRNAs ; RNA, Small Untranslated
    Language English
    Publishing date 2019-12-03
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2557172-2
    ISSN 2150-7511 ; 2161-2129
    ISSN (online) 2150-7511
    ISSN 2161-2129
    DOI 10.1128/mBio.01037-19
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top